Fig. 1
From: L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
L1CAM-positive cases among ProMisE subgroups: a Represented as absolute numbers b Represented as the percentage of each molecular subgroup. c Percentage of ProMisE subgroups among L1CAM positive and negative EC
